Drug Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alltracel Pharmaceuticals
Alltracel launches Nanopeutics to develop wound care products
November 7th, 2006
Alltracel Pharmaceuticals Plc., (AP, AP.L) has launched Nanopeutics s.r.o., a specialist joint venture with nanofiber technology developers Elmarco. Nanopeutics is dedicated to the commercialization of Nanospider technology for the global professional and consumer wound care markets and will be led by Ladislav Mares, current CEO of Elmarco, as chairman and by Camillus Glover, currently COO of Alltracel, as CEO. Elmarco is a specialist R&D and manufacturing company that has developed, in conjunction with the Technical University of Liberic, a novel proprietary and patented process for spinning polymers into nano-scale fibers for a range of industrial,...
Source: Drug Law Weekly (2006-11-07)
|
